You are here

Shoreline Biosciences

Editas, in next restructuring step, to sell cell therapy work to Shoreline

BioPharma Dive

Thu, 01/19/23 - 07:43 pm

Editas Medicine

natural killer cell therapy

Shoreline Biosciences

Editas finds buyer for iNK programs 10 days after clearing out pipeline

Fierce Biotech

Thu, 01/19/23 - 10:48 am

Editas Medicine

Shoreline Biosciences

Biotech Raises $140 Million to Advance iPSC-based Immunotherapies

BioSpace

Tue, 11/2/21 - 11:44 pm

Shoreline Biosciences

pluripotent stem cells

Five Collaborations Unlocking Faster Drug Development this Week

BioSpace

Thu, 06/10/21 - 11:12 am

drug development

pulmonary fibrosis

Oyster Point Pharma

Adaptive Phage Therapeutics

clinical trials

Shoreline Biosciences

BeiGene dives in on natural killer cells with discovery pact for small biotech's stem cell-based platform

Endpoints

Wed, 06/9/21 - 11:09 am

natural killer cells

Shoreline Biosciences